Michel Doyon

Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany.

inVentiv Health Clinical, Inc. provides clinical research and drug development services. It provides its services to the pharmaceutical, biotechnology, generic drug, and medical device industries. The firm offers clinical-development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical development programs. The company was founded in 1984 and is headquartered in Princeton, NJ.

Oddo BHF SCA (Broker) is the securities brokerage division of Oddo BHF SCA, a financial services company headquartered in Paris, France. The firm provides equity brokerage services to various investors.

Merz Pharmaceuticals GmbH discovers and develops drugs for the treatment of neurological and psychiatric diseases. Its dermatology products focus on the treatment of scars, acne, hair loss and fungal diseases. In the area of metabolic disturbances, it offers therapies for liver disease and lipid metabolism disorders. The company also offers various OTC products, including cold remedies, skin care products and vitamin supplements under the brand names tetesept and Merz Special. The company is headquartered in Frankfurt am Main, Germany.

SMA Gestion SA is an asset management firm headquartered in Paris, France. The firm was founded in 1997 and is a subsidiary of Société Auxiliaire d'Etudes et d'Investissements Mobiliers SA, ultimately owned by SGAM BTP. SMA Gestion manages mutual funds for individual and institutional investors.

Altergaz SA engages in the purchase, supply and sale of natural gas to individuals and communities as well as small and medium sized businesses. It also offers auditing for facility optimization, technical consulting, operation management assistance and facility financing services. The company was founded by Robert Delbos and Jean-Paul Georges in 2004 and is headquartered in Levallois-Perret, France.

Founded in 2006, ARCIM Advisors LLC is a hedge fund manager located in Greenwich, Connecticut.

Fairchild Participations SA operates as an investment company. It offers bonds, insurance, mutual funds and shares. The company is headquartered in Luxembourg.

Ordre des Ingénieurs du Québec operates as a self-regulatory body that governs Quebec's professional engineers. The firm specifically admits and supports its members, monitors and improves engineering practice and implements a disciplinary framework. It also conducts specific activities to promote prevention, raise the profile of the profession, improve and maintain competencies and ensure that engineers fulfill their ethical and professional obligations in their professional practice. The company was founded in February 14, 1920 and is headquartered in Montréal, Canada.

Aptus Health, Inc. operates a marketing platform for physicians and health care professionals. Its services include Geo-targeting mobile advertising; clinical alerts and eNewsletters; insight and attitudinal surveys; KOL-led presentations; eDetails; Peer-to-Peer collaboration; eSampling; Electronic Health Record integration; patient feedback; segmentation and tartgeting; behavioral insights; and intelligence and reporting. The company was founded by Donato J. Tramuto in 2008 and is headquartered in Reading, MA.

SNC-Lavalin, Inc. provides engineering and construction services. The company is headquartered in Montréal, Canada.

Paseosoft SAS provides process development solutions for automating, coordinating and supervising business processes. The firm offers vertical solutions tailored to operational needs. Its products include Paseo File Transfer, BPM, Paseo Mail Process, and Paseo Hypervision. The company was founded by Augustin Rousselet in 1995 and is headquartered in Aix-en-Provence, France.

PANHARD GENERAL Defense SASU manufactures armored vehicles. It offers light armored vehicles (VBL), for serving on a daily basis in operations with the French army, used for intelligence missions, patrolling and combats. The company was founded in 1965 and is headquartered in Marolles-en-Hurepoix, France.

JSS Medical Research, Inc. is a full service clinical research organization. It offers clinical trials, market access and HEOR, consulting, biostatistics and medical writing and insourcing services. The company was founded by John S. Sampalis in 1985 and is headquartered in Montreal, Canada.

Greenstone Capital LLP (Greenstone Capital) is an Independent Private Equity firm founded in 2013 by Michael John Haworth and Mark Raymond Sawyer. The firm is headquartered in London.

Abaques SASU is a French company that simplifies technology for its clients. The private company is based in Saint-Jean, France. The company specializes in audiovisual engineering and equipment integration.

Cohen Group, Inc. provides advertising services. The private company is based in Houston, TX.

Assala Energy UK Ltd. operates as a holding company that engages in oil exploration and production. It operates five fields and has four interests in four non-operated fields. The company is headquartered in London, the United Kingdom.

Nevada Gold Mines LLC is a joint venture company that mines for gold ores. The company is based in Carson City, NV. The company was founded in 2019. The CEO is Dennis Mark Bristow.

Part of Safi Biotherapeutics, Inc., EryPharm SAS is a biotech startup based in Paris, France. EryPharm is focused on the development of cultured red blood cells (CRBCs) technology, which was pioneered by the team in 2002. The French company aims to confirm the product's non-toxicity through clinical trials in 2022, followed by trials in 2023 to confirm the benefits of CRBCs. The go-to-market authorization is expected in 2028 at the latest. EryPharm SAS was founded in 2016 by Prof. Luc Douay's team, a spin-off from Sorbonne University. The CEO is Daniel Marini. EryPharm was acquired by Safi Biotherapeutics, Inc. on January 05, 2024.